Actionable news
All posts from Actionable news
Actionable news in EXAC: Exactech, Inc.,

Exactech Receives FDA 510(k) Clearance for Vantage™ Total Ankle

GAINESVILLE, Fla., Apr 25, 2016 (BUSINESS WIRE) -- Exactech Inc. EXAC, +1.52% a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, announced today it has received clearance from the U.S. Food and Drug Administration to market the Vantage™ Total Ankle to treat patients who suffer from arthritis in the ankle. The Vantage Total Ankle is the latest product in the company’s extremities line, and its first in the foot and ankle market.

“With the introduction of the Vantage Ankle, Exactech continues its precedent of innovation in the extremities market, which began with our industry-leading Equinoxe [®] platform shoulder system,” said Darin Johnson, Exactech vice president of marketing for extremities. “The ankle market is in need of advances in total ankle technologies. We have had the pleasure of working with a world-class design team that includes surgeons who have dedicated their careers to treatment of the ankle. Together, we have developed an implant that we believe will be an improvement for patients who need a total ankle.”

“I am impressed with Exactech’s ability to convert concepts from their other successful total joint replacement systems,” said Mark Easley, MD, design team member and president of the American Orthopaedic Foot and Ankle Society. “The company’s engineers have successfully turned our ideas into an exciting new treatment...